Mesenchymal stem cells attenuate acute liver injury by altering ratio between interleukin 17 producing and regulatory natural killer T cells.

Milosavljevic, Neda; Gazdic, Marina; Simovic Markovic, Bojana; Arsenijevic, Aleksandar; Nurkovic, Jasmin; Dolicanin, Zana; Djonov, Valentin; Lukic, Miodrag L; Volarevic, Vladislav (2017). Mesenchymal stem cells attenuate acute liver injury by altering ratio between interleukin 17 producing and regulatory natural killer T cells. Liver transplantation, 23(8), pp. 1040-1050. Wiley 10.1002/lt.24784

[img] Text
lt24784.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (866kB) | Request a copy

Mesenchymal stem cells (MSCs) are, due to immunomodulatory characteristics, considered as novel agents in the treatment of immune-mediated acute liver failure. Although it is known that MSCs can regulate activation of T lymphocytes, their capacity to modulate function of neutrophils and natural killer T (NKT) cells, major interleukin (IL) 17-producing cells in acute liver injury, is still unknown. By using 2 well-established murine models of neutrophil and NKT cell-mediated acute liver failure (induced by carbon tetrachloride and α-galactoceramide), we investigated molecular and cellular mechanisms involved in MSC-mediated modulation of IL17 signaling during acute liver injury. Single intravenous injection of MSCs attenuate acute hepatitis and hepatotoxicity of NKT cells in a paracrine, indoleamine 2,3-dioxygenase (IDO)-dependent manner. Decreased levels of inflammatory IL17 and increased levels of immunosuppressive IL10 in serum, reduced number of interleukin 17-producing natural killer T (NKT17) cells, and increased presence of forkhead box P3 + IL10-producing natural killer T regulatory cells (NKTregs) were noticed in the injured livers of MSC-treated mice. MSCs did not significantly alter the total number of IL17-producing neutrophils, CD4+, and CD8 + T lymphocytes in the injured livers. Injection of mesenchymal stem cell-conditioned medium (MSC-CM) resulted with an increased NKTreg/NKT17 ratio in the liver and attenuated hepatitis in vivo and significantly reduced hepatotoxicity of NKT cells in vitro. This phenomenon was completely abrogated in the presence of IDO inhibitor, 1-methyltryptophan. In conclusion, the capacity of MSCs to alter NKT17/NKTreg ratio and suppress hepatotoxicity of NKT cells in an IDO-dependent manner may be used as a new therapeutic approach in IL17-driven liver inflammation. Liver Transplantation 23 1040-1050 2017 AASLD.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Anatomy
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Anatomy > Topographical and Clinical Anatomy

UniBE Contributor:

Djonov, Valentin and Volarevic, Vladislav

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1527-6465

Publisher:

Wiley

Language:

English

Submitter:

David Christian Haberthür

Date Deposited:

18 Jan 2018 09:27

Last Modified:

22 Oct 2019 19:50

Publisher DOI:

10.1002/lt.24784

PubMed ID:

28481005

BORIS DOI:

10.7892/boris.108996

URI:

https://boris.unibe.ch/id/eprint/108996

Actions (login required)

Edit item Edit item
Provide Feedback